G-circulating liposomes can alter their pharmacokinetic pattern and cut down MPS uptake
G-circulating liposomes can alter their pharmacokinetic pattern and decrease MPS uptake (four). Furthermore, liposomes that have been modified with glycolipid-targeted ligandsare promising as a long-circulating and tumor-targeting carrier system (five).…